Table 1.
General characteristics of the study cohort.
| Characteristic | Category | Value |
|---|---|---|
| Graft type; number (percentage) | PB | 118 (76.1) |
| BM | 37 (23.9) | |
| Acute GvHD grade; number (percentage) | 0 | 94 (59.9) |
| 1 | 28 (17.8) | |
| 2 | 19 (12.1) | |
| 3 & 4 | 16 (10.2) | |
| Chronic GvHD grade; number (percentage) | No | 77 (51.0) |
| Limited | 23 (15.2) | |
| Extensive | 51 (33.8) | |
| Relapse occurrence; number (percentage) | Yes | 47 (30.1) |
| No | 109 (69.9) | |
| Recipient-mismatched peptides; mean (95% CI) | 872,895 (627,999–1,375,167) | |
| Filtered recipient-mismatched peptides; mean (95% CI) | 28,146 (17,925–44,979) | |
| M1; mean (95% CI) | 393 (88–889) | |
| M2; mean (95% CI) | 21.6 (3.0–47.1) | |
| M3; mean (95% CI) | 2.6 (0.0–10.1) | |
| M4; mean (95% CI) | 39.5 (2.0–172.6) | |
For explanations of analysis approaches M1–M4 (see Table 2).